期刊
JOURNAL OF IMMUNOLOGY
卷 182, 期 7, 页码 4423-4431出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0802457
关键词
-
类别
资金
- UAB Clinical Investigative Fellowship Award [MO1RR00032]
- Cystic Fibrosis Foundation [GAGGAR07A0, R464-CR02]
- National Institutes of Health [HL07783, HL090999, T32A107493]
- NCI [P30 CA 13148]
Lung transplantation is a therapeutic modality frequently used in end-stage lung disease. Unfortunately, lung transplant recipients have poor clinical outcomes, often due to the development of bronchiolitis obliterans syndrome (BOS). This process is often characterized by the pathologic findings of obliterative bronchiolitis: neutrophil influx and extracellular matrix remodeling leading to luminal obstruction and airway inflammation. The molecular mechanisms underlying BOS are poorly understood and disease-specific biomarkers are lacking. We report that in addition to increased levels of IL-8, the level of the neutrophil chemoattractant proline-glycine-proline (PGP) is elevated in BOS patient bronchoalveolar lavage (BAL) fluid. The enzymes responsible for generating PGP, matrix metalloproteases 8 and -9 and prolyl endopeptidase, are also elevated in these samples. Together, IL-8 and PGP account for most of the neutrophil chemoattractant capacity seen in BOS BAL fluid. Using specific neutralizing Abs to both IL-8 and PGP, we demonstrate that PGP is a prominent neutrophil chemoattractant found in BAL fluid from individuals at the time of diagnosis of BOS. These findings highlight the influence of a matrix-derived neutrophil chemoattractant in post-transplantation. BOS and provide opportunities for the development of unique diagnostics and therapeutics to potentially improve disease outcomes. The Journal of Immunology, 2009, 182: 4423-4431.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据